We are live on
!
Find out more
B
Bellecapital Portfolio holdings
AUM
$625M
Turnover
41.45%
1-Year Est. Return
39.69%
This Fund
S&P 500
This Quarter
Est. Return
+15.6%
1 Year Est. Return
+39.69%
3 Year Est. Return
+127.77%
5 Year Est. Return
+155.51%
10 Year Est. Return
+530.96%
AUM
$300M
AUM Growth
+$81.3M
(+37%)
Cap. Flow
+$53.7M
Cap. Flow
% of AUM
17.92%
Top 10 Holdings %
Top 10 Hldgs %
30.67%
Holding
195
New
35
Increased
77
Reduced
34
Closed
15
Avg Time Held
1.5
years
Top 10 Avg Time Held
1.8
years
Top 20 Avg Time Held
2.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ARK Genomic Revolution ETF
ARKG
|
+$7.21M |
| 2 |
Tencent Music
TME
|
+$6.16M |
| 3 |
MakeMyTrip
MMYT
|
+$5.61M |
| 4 |
ZTO Express
ZTO
|
+$5.17M |
| 5 |
Health Catalyst
HCAT
|
+$3.76M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Biotechnology ETF
IBB
|
+$5.96M |
| 2 |
SPDR Gold Trust
GLD
|
+$1.3M |
| 3 |
BSJK
Invesco BulletShares 2020 High Yield Corporate Bond ETF
BSJK
|
+$1.29M |
| 4 |
IBDL
iShares iBonds Dec 2020 Term Corporate ETF
IBDL
|
+$935K |
| 5 |
Clorox
CLX
|
+$765K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.52% |
| 2 | Miscellaneous | 17.57% |
| 3 | Consumer Discretionary | 15.83% |
| 4 | Healthcare | 12.25% |
| 5 | Communication Services | 9.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Apple
AAPL
$5.01T
| $15.9M | 5.31% |
120,075
+25,474
| +27% | +$3.06M |
2013 Q4
28 quarters
|
|
2
Alphabet (Google) Class A
GOOGL
$4.27T
| $10.6M | 3.54% |
121,240
+2,360
| +2% | +$199K |
2015 Q4
20 quarters
|
|
3
Alibaba
BABA
$275B
| $9.93M | 3.31% |
42,657
+1,570
| +4% | +$436K |
2015 Q4
20 quarters
|
|
4
Amazon
AMZN
$2.73T
| $9.35M | 3.12% |
57,420
+1,000
| +2% | +$160K |
2013 Q4
28 quarters
|
|
|
5
ARK Genomic Revolution ETF
ARKG
$2.07B
| $8.44M | 2.82% |
+90,517
| New | +$7.21M |
2020 Q4
0 quarters
|
|
6
Microsoft
MSFT
$3.99T
| $7.85M | 2.62% |
35,279
+4,634
| +15% | +$996K |
2016 Q1
19 quarters
|
|
7
Starbucks
SBUX
$109B
| $7.73M | 2.58% |
72,262
+1,327
| +2% | +$127K |
2017 Q3
13 quarters
|
|
8
Coca-Cola
KO
$400B
| $7.52M | 2.51% |
137,099
-7,115
| -5% | -$368K |
2017 Q4
12 quarters
|
|
|
9
Tencent Music
TME
$14B
| $7.3M | 2.43% |
+379,223
| New | +$6.16M |
2020 Q4
0 quarters
|
|
|
10
MakeMyTrip
MMYT
$4.45B
| $7.29M | 2.43% |
+246,992
| New | +$5.61M |
2020 Q4
0 quarters
|
|
11
PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund
HYS
$1.67B
| $6.81M | 2.27% |
69,341
+25,337
| +58% | +$2.43M |
2020 Q2
2 quarters
|
|
12
AbbVie
ABBV
$510B
| $6.79M | 2.27% |
63,410
+3,473
| +6% | +$334K |
2016 Q2
18 quarters
|
|
|
PRAH
13
DELISTED
PRA Health Sciences, Inc.
PRAH
| $6.73M | 2.24% |
53,662
+4,989
| +10% | +$558K |
2017 Q2
14 quarters
|
|
14
Cisco
CSCO
$429B
| $6.59M | 2.2% |
147,209
+14,142
| +11% | +$581K |
2014 Q1
27 quarters
|
|
15
Fiserv Inc
FISV
$25B
| $6.36M | 2.12% |
55,888
+5,290
| +10% | +$570K |
2020 Q2
2 quarters
|
|
|
16
ZTO Express
ZTO
$15B
| $5.93M | 1.98% |
203,336
+176,049
| +645% | +$5.17M |
2018 Q1
11 quarters
|
|
17
Logitech
LOGI
$14.9B
| $5.58M | 1.86% |
61,472
-4,664
| -7% | -$403K |
2019 Q3
5 quarters
|
|
18
Walmart Inc
WMT
$947B
| $5.41M | 1.8% |
112,614
+6,063
| +6% | +$294K |
2015 Q4
20 quarters
|
|
19
Fastenal
FAST
$58B
| $5.4M | 1.8% |
221,196
+5,808
| +3% | +$137K |
2017 Q3
13 quarters
|
|
20
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23.4B
| $5.01M | 1.67% |
90,797
+44,418
| +96% | +$2.44M |
2019 Q1
7 quarters
|
|
21
Intercontinental Exchange
ICE
$88.7B
| $4.65M | 1.55% |
40,342
+4,460
| +12% | +$463K |
2019 Q4
4 quarters
|
|
|
22
Health Catalyst
HCAT
$134M
| $4.44M | 1.48% |
+101,938
| New | +$3.76M |
2020 Q4
0 quarters
|
|
|
23
SPDR Gold Trust
GLD
$141B
| $4.2M | 1.4% |
23,572
-7,370
| -24% | -$1.3M |
2013 Q4
28 quarters
|
|
24
Procter & Gamble
PG
$369B
| $4.18M | 1.39% |
30,012
+4,288
| +17% | +$599K |
2013 Q4
28 quarters
|
|
25
Cooper Companies
COO
$10.8B
| $3.99M | 1.33% |
43,968
+428
| +1% | +$36.7K |
2016 Q2
18 quarters
|
|
Similar funds
TAM
RIP
CWM
LWP
FGA
BVC
APM
PIM
Bellecapital's Q4 2020 Portfolio in Review
As of Q4 2020, Bellecapital held 195 positions worth $300M, up 37% from $219M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Bellecapital deployed $53.7M of net new capital in Q4 2020, opening 35 new positions and adding to 77 existing holdings. Its largest new stake was ARK Genomic Revolution ETF: 90,517 shares worth $8.44M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Miscellaneous and Consumer Discretionary.
On the sell side, the largest reduction was SPDR Gold Trust, an estimated $1.3M trimmed.
- Bellecapital's largest Q4 2020 buy was ARK Genomic Revolution ETF: 90,517 shares worth $8.44M.
- Bellecapital added most to ZTO Express in Q4 2020, an estimated $5.17M increase.
- Bellecapital's biggest Q4 2020 reduction was SPDR Gold Trust, cutting an estimated $1.3M.
- Bellecapital fully exited iShares Biotechnology ETF in Q4 2020, selling an estimated $5.96M.
- Bellecapital's ten largest holdings make up 31% of its $300M portfolio in Q4 2020.
- Bellecapital opened 35 new positions and closed 15 in Q4 2020.
- Bellecapital's portfolio value rose 37% quarter-over-quarter to $300M.
Based on Bellecapital's 13F filing for Q4 2020, filed 14 Jan 2021.